✦ LIBER ✦

Fat composition is the differential factor to explain the primary therapeutic effect of enteral nutrition in Crohn's disease. Results of a double-blind, randomized, multicenter european trial

✍ Scribed by Miquel A. Gassull; Fernando Fernandez-Banares; Eduard Cabre; Michel Papo; M.H. Giaffer; Jose L. Sanchez-Lornbrana; Juan C. Quer; Helmut Malchow; Ferran Gonzalez-Huix

Book ID: 119425665
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 191 KB
Volume: 118
Category: Article
ISSN: 0016-5085
DOI: 10.1016/s0016-5085(00)82545-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Su2091 Results of a Phase II, Randomized

Su2091 Results of a Phase II, Randomized, Double Blind, Controlled Trial of the Efficacy of Active Therapeutic Immunization With TNF-Kinoid in Patients With Moderate to Severe Crohn's Disease With Secondary Resistance to TNFα Antagonist

✍ Dewit, Olivier; Hebuterne, Xavier; Dupas, Jean-Louis; Howaldt, Stefanie M.; Bure 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 176 KB

A Multicenter, Randomized, Double-Blind,

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase2b Study of Ustekinumab, a Human Monoclonal Antibody to IL-12/23p40, in Patients With Moderately to Severely Active Crohn's Disease: Results Through Week 22 From the Certifi Trial

✍ William J. Sandborn; Christopher Gasink; Long-Long Gao; Marion Blank; Jewel Joha 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 145 KB